SARS-CoV-2 Omicron BA.2 Pseudovirus variant

SARS-CoV-2 Omicron Pseudovirus uses HIV pseudotyped with SARS-CoV-2 spike protein and a firefly luciferase reporter. This pseudovirus effectively infects human ACE2 overexpressing cells and can be used to screen for inhibitors of Spike-ACE2 interaction, determine neutralizing antibody titers, and is a valuable tool for COVID-19 vaccine development as well.

43740568

P0DTC1

QHD43416

Pseudovirus

HEK293 cells

Infectious Disease, COVID-19

DMEM/10% FBS

Dry Ice

The pseudovirus is stable in a liquid state at -70˚ for 12 months. Avoid repeated freeze-thaw cycles.

Click here to download6

Surface glycoprotein

Severe acute respiratory syndrome coronavirus 2

Spike glycoprotein Receptor-binding domain, S glycoprotein, Spike protein, Omicron variant spike, Omicron variant pseudovirus, Omicron, pseudovirus reporter, reporter virus particle

Neutralization assay, Viral Infection

SARS-CoV-2 (COVID-19) Spike pseudovirus

1791269090

Liquid